我国首例侵入式脑机接口临床试验成功开展

Core Viewpoint - The development of brain-computer interface (BCI) technology in China is rapidly advancing, with the country becoming the second globally to enter clinical trials for invasive BCI technology after the United States [1][5]. Group 1: Clinical Trial Progress - The first invasive BCI clinical trial in China has been successfully conducted in collaboration with the Chinese Academy of Sciences and Fudan University Huashan Hospital [1]. - The trial's participant, who lost limbs due to an electrical accident, has demonstrated the ability to control a cursor on a computer and play games within 2-3 weeks of training after the implantation surgery [3]. Group 2: Technology and Innovation - Invasive BCIs are categorized as having the highest technical challenges and barriers, with the only previous clinical trial being conducted by Neuralink [5]. - The Chinese-developed invasive BCI system is coin-sized and features ultra-flexible neural electrodes that are implanted into the brain tissue through minimally invasive surgery, with each electrode having 32 sensors to capture weak neural signals [5]. Group 3: Future Implications - The technology has the potential to significantly improve the quality of life for individuals with disabilities, such as restoring vision, speech, and mobility, as well as providing better interventions for conditions like stroke and Alzheimer's disease [6]. - Furthermore, this cutting-edge technology could revolutionize communication with the external world, enabling not only brain control but also the ability to write information directly into the brain, paving the way for a future of human-machine coexistence [6].